Survival in Ecuadorian Patients with Prostate Cancer Clinically Treated with Radiotherapy and Chemotherapy

<strong>Foundation:</strong> prostate cancer is a common oncological condition in men. The study of treatments, effectiveness and survival is a necessity.<br /> <strong>Objective</strong>: to compare survival in ecuadorian patients with prostate cancer treated clinicall...

Full description

Saved in:
Bibliographic Details
Main Authors: Alberto Sánchez Garrido, Guido Nino Guida Acevedo, Becker Neto Mullo
Format: Article
Language:Spanish
Published: Centro Provincial de Información de Ciencias Médicas. Cienfuegos 2024-01-01
Series:Medisur
Subjects:
Online Access:http://medisur.sld.cu/index.php/medisur/article/view/45114
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576838210158592
author Alberto Sánchez Garrido
Guido Nino Guida Acevedo
Becker Neto Mullo
author_facet Alberto Sánchez Garrido
Guido Nino Guida Acevedo
Becker Neto Mullo
author_sort Alberto Sánchez Garrido
collection DOAJ
description <strong>Foundation:</strong> prostate cancer is a common oncological condition in men. The study of treatments, effectiveness and survival is a necessity.<br /> <strong>Objective</strong>: to compare survival in ecuadorian patients with prostate cancer treated clinically with radiotherapy and chemotherapy in a hospital in the Amazon region. <br /><strong>Method:</strong> an observational, analytical prospective cohort study was carried out in 74 patients with prostate cancer. The variables were analyzed: survival time, treatment, survival function, risk function. It was developed in two phases, in the first the average survival time of the patients was calculated, while in the second the comparison of survival between patients treated with radiotherapy and chemotherapy was carried out. The Chi-square test and the Log Rank (Mantel-Cox) statistic were used to evaluate significant differences in survival distributions between the groups. <br /><strong>Results:</strong> the mean overall survival was 46.2 months; higher in the group that received radiotherapy (50.3 months) compared to the chemotherapy group (39.4 months). Greater cumulative survival was observed in patients who received radiotherapy. In the chemotherapy group, the cumulative risk curve tended to increase more steeply as the months passed compared to the radiotherapy group; however, no statistically significant difference in survival was identified between groups (p &gt; 0 .05) <br /><strong>Conclusions:</strong> greater survival was found in the group that received radiotherapy, however, no significant difference in survival was found between groups.
format Article
id doaj-art-81f333cbcfd54d50b417b0789d00f5d7
institution Kabale University
issn 1727-897X
language Spanish
publishDate 2024-01-01
publisher Centro Provincial de Información de Ciencias Médicas. Cienfuegos
record_format Article
series Medisur
spelling doaj-art-81f333cbcfd54d50b417b0789d00f5d72025-01-30T21:29:02ZspaCentro Provincial de Información de Ciencias Médicas. CienfuegosMedisur1727-897X2024-01-0121691982437Survival in Ecuadorian Patients with Prostate Cancer Clinically Treated with Radiotherapy and ChemotherapyAlberto Sánchez Garrido0Guido Nino Guida Acevedo1Becker Neto Mullo2Universidad Regional Autónoma de los Andes. Ambato. Ecuador.Universidad Regional Autónoma de los Andes. Santo Domingo. Ecuador.Universidad Regional Autónoma de los Andes. Ambato. Ecuador.<strong>Foundation:</strong> prostate cancer is a common oncological condition in men. The study of treatments, effectiveness and survival is a necessity.<br /> <strong>Objective</strong>: to compare survival in ecuadorian patients with prostate cancer treated clinically with radiotherapy and chemotherapy in a hospital in the Amazon region. <br /><strong>Method:</strong> an observational, analytical prospective cohort study was carried out in 74 patients with prostate cancer. The variables were analyzed: survival time, treatment, survival function, risk function. It was developed in two phases, in the first the average survival time of the patients was calculated, while in the second the comparison of survival between patients treated with radiotherapy and chemotherapy was carried out. The Chi-square test and the Log Rank (Mantel-Cox) statistic were used to evaluate significant differences in survival distributions between the groups. <br /><strong>Results:</strong> the mean overall survival was 46.2 months; higher in the group that received radiotherapy (50.3 months) compared to the chemotherapy group (39.4 months). Greater cumulative survival was observed in patients who received radiotherapy. In the chemotherapy group, the cumulative risk curve tended to increase more steeply as the months passed compared to the radiotherapy group; however, no statistically significant difference in survival was identified between groups (p &gt; 0 .05) <br /><strong>Conclusions:</strong> greater survival was found in the group that received radiotherapy, however, no significant difference in survival was found between groups.http://medisur.sld.cu/index.php/medisur/article/view/45114cáncer prostáticoradioterapiaquimioterapiasupervivencia
spellingShingle Alberto Sánchez Garrido
Guido Nino Guida Acevedo
Becker Neto Mullo
Survival in Ecuadorian Patients with Prostate Cancer Clinically Treated with Radiotherapy and Chemotherapy
Medisur
cáncer prostático
radioterapia
quimioterapia
supervivencia
title Survival in Ecuadorian Patients with Prostate Cancer Clinically Treated with Radiotherapy and Chemotherapy
title_full Survival in Ecuadorian Patients with Prostate Cancer Clinically Treated with Radiotherapy and Chemotherapy
title_fullStr Survival in Ecuadorian Patients with Prostate Cancer Clinically Treated with Radiotherapy and Chemotherapy
title_full_unstemmed Survival in Ecuadorian Patients with Prostate Cancer Clinically Treated with Radiotherapy and Chemotherapy
title_short Survival in Ecuadorian Patients with Prostate Cancer Clinically Treated with Radiotherapy and Chemotherapy
title_sort survival in ecuadorian patients with prostate cancer clinically treated with radiotherapy and chemotherapy
topic cáncer prostático
radioterapia
quimioterapia
supervivencia
url http://medisur.sld.cu/index.php/medisur/article/view/45114
work_keys_str_mv AT albertosanchezgarrido survivalinecuadorianpatientswithprostatecancerclinicallytreatedwithradiotherapyandchemotherapy
AT guidoninoguidaacevedo survivalinecuadorianpatientswithprostatecancerclinicallytreatedwithradiotherapyandchemotherapy
AT beckernetomullo survivalinecuadorianpatientswithprostatecancerclinicallytreatedwithradiotherapyandchemotherapy